Due to its silent nature, proactive screening is essential, especially for individuals with risk factors. These include people who are overweight or obese, have Type 2 diabetes, high blood pressure, or elevated cholesterol levels. The disease is characterised by the accumulation of excess fat in the liver.
Metabolic Dysfunction-Associated Steatotic Liver Disease, or MASLD, is emerging as a significant health concern, particularly in India. Previously known as Non-Alcoholic Fatty Liver Disease (NAFLD), its name was changed to better reflect the condition’s underlying causes. The new term highlights that the disease is a metabolic one, linked to factors such as obesity, diabetes, and high cholesterol. Often referred to as a “silent” disease, MASLD is a liver condition that can progress over time if left unaddressed.
The disease is characterised by the accumulation of excess fat in the liver. While this may not cause immediate symptoms, it can lead to inflammation and, in severe cases, irreversible liver damage. The global prevalence of MASLD is staggering, with a significant portion of the Indian population being affected, particularly middle-aged and older men. Its silent nature is one of its most dangerous aspects, as many people are unaware that they have it in the early stages, making early detection and intervention critical to prevent its progression.
📌 Causes (Risk Factors)
1. Metabolic Causes
- Obesity (especially central/abdominal obesity)
- Insulin resistance & Type 2 diabetes
- Dyslipidemia (high triglycerides, low HDL)
- Metabolic syndrome
2. Lifestyle Causes
- High-calorie diet (refined carbs, sugary drinks, saturated fats)
- Physical inactivity / sedentary lifestyle
3. Genetic & Other Factors
- Family history of fatty liver
- Certain medications (e.g., steroids, amiodarone, methotrexate)
- Rapid weight loss or malnutrition
⚠️ Effects (Consequences / Complications)
On the Liver
- Simple steatosis → fat in liver
- MASH (Metabolic dysfunction–associated steatohepatitis) → inflammation
- Fibrosis → scarring
- Cirrhosis
- Hepatocellular carcinoma (liver cancer)
On the Body
- Increased risk of:
- Cardiovascular disease
- Type 2 diabetes complications
- Chronic kidney disease
🛠️ Remedy / Management (Treatment & Prevention)
1. Lifestyle Modification (Mainstay of Treatment)
- Weight loss (7–10% body weight can reverse inflammation/fibrosis)
- Healthy diet
- Mediterranean diet
- Reduce sugar, refined carbs, and saturated fat
- Regular physical activity
- ≥150 min/week moderate exercise
2. Control Metabolic Risk Factors
- Good blood sugar control
- Manage cholesterol & triglycerides
- Treat hypertension
3. Medications (When Prescribed by a Doctor)
- Vitamin E (in selected non-diabetic patients)
- Pioglitazone (in patients with MASH & diabetes)
- GLP-1 receptor agonists (e.g., semaglutide for weight loss)
(No single drug cures MASLD, but these help in selected cases.)
4. Avoid Liver Stress
- Avoid alcohol or keep it minimal
- Avoid unnecessary medications/toxins
✅ Prevention Tips
- Maintain healthy weight
- Eat balanced meals
- Exercise regularly
- Get routine health checkups